Charles E. Geyer, MD

Charles E. Geyer, MD, is a professor of medicine and chief of Malignant Hematology and Medical Oncology in the Department of Medicine at the University of Pittsburgh and the University of Pittsburgh Medical Center Hillman Cancer Center

Articles by Charles E. Geyer, MD

Breast cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com

Dr Geyer on ILD and Radiation Pneumonitis Data With T-DXd in DESTINY-Breast05

ByCharles E. Geyer, MD

August 27th 2026

Charles E. Geyer, MD, discusses ILD and radiation pneumonitis incidence by radiotherapy timing with T-DXd in a DESTINY-Breast05 safety analysis.

FDA Approval Insights: T-DXd for Early-Stage HER2+ Breast Cancer: With Charles E. Geyer, MD

ByCharles E. Geyer, MD

June 30th 2026

Charles E. Geyer, MD, discusses the FDA approvals of trastuzumab deruxtecan for the management of early-stage HER2-positive breast cancer.

Dr Geyer on the FDA Approval of T-DXd Followed by THP for HER2+ Breast Cancer

ByCharles E. Geyer, MD

June 30th 2026

Charles E. Geyer, MD, discusses the significance of the FDA approval of neoadjuvant T-DXd followed by THP for patients with HER2-positive breast cancer.